Onconova Therapeutics IPO Research Information

Onconova Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Onconova Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Onconova Therapeutics	ONTX - NASDAQ	$12.00-$14.00	$15.00	$25.00	5.2 million	7/25/2013
Underwriter(s): Citigroup, Leerink Swann
Co-Manager(s): Piper Jaffray, Janney Montgomery Scott
Industry: Health Care
Filing(s): Filed 2013-06-14

Onconova Therapeutics Quote & Chart - Click for current quote - ONTX

About Onconova Therapeutics (adapted from Onconova Therapeutics prospectus):
They are a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ONTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.